Protocol Ledger

NCT05766839 · Phase II · RECRUITING

Effect of Patiromer in Children Under 12 Years of Age With High Blood Potassium Levels

Interventional Phase II clinical trial protocol NCT05766839 sponsored by Vifor Pharma in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-04-06 Enrollment: 36 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05766839
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)36 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05766839
Protocol FieldVerified Registry Value
NCT IdentifierNCT05766839
Consolidated Lead SponsorVifor Pharma
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment36 participants (ESTIMATED)
Registered Start Date2025-04-06
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI